Hammond, H. R., Eans, S. O., Cirino, T. J., Ananthan, S., Jimenez-Torres, A. C., Zhu, J., & McLaughlin, J. P. (2024). SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice. NeuroImmune Pharmacology & Therapeutics, 3(1), 1. https://doi.org/10.1515/nipt-2023-0022
Chicago Style (17th ed.) CitationHammond, Haylee R., Shainnel O. Eans, Thomas J. Cirino, Subramaniam Ananthan, Ana Catya Jimenez-Torres, Jun Zhu, and Jay P. McLaughlin. "SRI-30827, a Novel Allosteric Modulator of the Dopamine Transporter, Alleviates HIV-1 Tat-induced Potentiation of Cocaine Conditioned Place Preference in Mice." NeuroImmune Pharmacology & Therapeutics 3, no. 1 (2024): 1. https://doi.org/10.1515/nipt-2023-0022.
MLA (9th ed.) CitationHammond, Haylee R., et al. "SRI-30827, a Novel Allosteric Modulator of the Dopamine Transporter, Alleviates HIV-1 Tat-induced Potentiation of Cocaine Conditioned Place Preference in Mice." NeuroImmune Pharmacology & Therapeutics, vol. 3, no. 1, 2024, p. 1, https://doi.org/10.1515/nipt-2023-0022.
